Designed to support the development of vaccines for the 2025-2026 northern hemisphere influenza season, the new offerings include high-quality recombinant HA, NA, and NP proteins. These reagents are ...

The study successfully mapped the intricate details of the influenza A virus’s RNP architecture by employing cryo-EM, revealing that partial deletion of the NP N-terminal tail stabilizes the ...

The ribonucleoprotein complex comprises a viral RNA segment associated with the nucleoprotein (NP) and three polymerase proteins (PA, PB1, and PB2). The matrix (M1) protein is associated with both ...